Keywords: growth, continues, merck, kgaa, based, darmstadt, germany
Growth continues at Merck KGaA
Article | 29 June 1999
Merck KGaA, based in Darmstadt, Germany, says that sales increased 8.3%to 3.72 billion Deutschemarks ($1.97 billion) for the first five months of 1999, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
